BISOGNI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 3.801
AS - Asia 2.025
EU - Europa 986
SA - Sud America 325
AF - Africa 308
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 38
Totale 7.562
Nazione #
US - Stati Uniti d'America 3.584
SG - Singapore 603
CN - Cina 404
IT - Italia 266
HK - Hong Kong 243
VN - Vietnam 228
BR - Brasile 176
BD - Bangladesh 108
FI - Finlandia 77
DE - Germania 76
FR - Francia 72
IN - India 67
SE - Svezia 64
GB - Regno Unito 56
NL - Olanda 55
CA - Canada 45
PL - Polonia 45
IQ - Iraq 36
RU - Federazione Russa 33
JP - Giappone 31
PH - Filippine 30
AR - Argentina 25
TR - Turchia 25
CO - Colombia 23
MX - Messico 20
ID - Indonesia 19
PK - Pakistan 19
SA - Arabia Saudita 19
CR - Costa Rica 18
EC - Ecuador 18
UA - Ucraina 18
ZA - Sudafrica 18
ES - Italia 15
JM - Giamaica 15
MA - Marocco 15
UZ - Uzbekistan 15
VE - Venezuela 15
CL - Cile 14
KR - Corea 14
BO - Bolivia 13
BY - Bielorussia 13
CI - Costa d'Avorio 13
NP - Nepal 13
PA - Panama 13
PT - Portogallo 13
TN - Tunisia 13
AU - Australia 12
CH - Svizzera 12
CU - Cuba 12
HN - Honduras 12
MD - Moldavia 12
PE - Perù 12
PY - Paraguay 12
SO - Somalia 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
EE - Estonia 11
ET - Etiopia 11
GM - Gambi 11
SI - Slovenia 11
TH - Thailandia 11
XK - ???statistics.table.value.countryCode.XK??? 11
CV - Capo Verde 10
KE - Kenya 10
LY - Libia 10
MR - Mauritania 10
PR - Porto Rico 10
UG - Uganda 10
AT - Austria 9
CG - Congo 9
GT - Guatemala 9
IL - Israele 9
KH - Cambogia 9
LV - Lettonia 9
MK - Macedonia 9
RS - Serbia 9
TW - Taiwan 9
AF - Afghanistan, Repubblica islamica di 8
AO - Angola 8
BE - Belgio 8
BF - Burkina Faso 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
MY - Malesia 8
PG - Papua Nuova Guinea 8
SK - Slovacchia (Repubblica Slovacca) 8
YT - Mayotte 8
ZM - Zambia 8
AL - Albania 7
BB - Barbados 7
BS - Bahamas 7
BZ - Belize 7
CY - Cipro 7
GN - Guinea 7
IE - Irlanda 7
KG - Kirghizistan 7
KZ - Kazakistan 7
MG - Madagascar 7
Totale 7.218
Città #
Ashburn 467
Fairfield 398
Singapore 377
San Jose 340
Chandler 225
Woodbridge 220
Hong Kong 208
Houston 158
Seattle 156
Cambridge 137
Ann Arbor 119
Wilmington 117
Council Bluffs 90
Santa Clara 86
Beijing 83
Ho Chi Minh City 71
New York 69
Los Angeles 65
Boardman 63
Hanoi 55
Helsinki 54
Padova 49
San Diego 39
Medford 36
Princeton 34
Lauterbourg 33
Guangzhou 32
Des Moines 29
Buffalo 25
Baghdad 23
Munich 23
Bytom 20
Roxbury 20
São Paulo 19
Milan 18
Orem 18
Nanjing 16
Brooklyn 14
San José 14
Tokyo 14
Denver 13
Haiphong 13
Panama City 13
Rome 13
Shanghai 13
Tashkent 13
Warsaw 13
Abidjan 12
Havana 12
Montreal 12
Toronto 12
Dallas 11
Montevideo 11
Phoenix 11
Addis Ababa 10
Atlanta 10
Baku 10
Redondo Beach 10
Tallinn 10
Amsterdam 9
Chicago 9
Jinan 9
Johannesburg 9
Kampala 9
Minsk 9
Nairobi 9
Nouakchott 9
Phnom Penh 9
Pristina 9
Boston 8
Chennai 8
Jeddah 8
Lima 8
London 8
Miami 8
San Francisco 8
Antananarivo 7
Bangkok 7
Banjul 7
Bogotá 7
Brasília 7
Bridgetown 7
Conakry 7
Da Nang 7
Dublin 7
Falkenstein 7
Guatemala City 7
Hargeisa 7
La Paz 7
Luanda 7
Managua 7
Maputo 7
Naples 7
Paris 7
Port Moresby 7
Tianjin 7
Andorra la Vella 6
Bologna 6
Charlotte 6
Dammam 6
Totale 4.566
Nome #
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 317
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 298
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 280
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 279
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 276
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 274
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 258
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 246
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 241
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 238
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 235
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 225
Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease. 225
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 222
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 217
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 216
Analysis of short-term blood pressure variability in pheochromocytoma/paraganglioma patients. 214
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 210
Recent advances in the diagnosis and management of obstructive sleep apnea 204
Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: Case report and appraisal of the pathophysiology. 197
Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. 196
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 193
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 186
A rare case report of hypertrophic cardiomyopathy induced by catecholamine-producing tumor 184
Munchausen syndrome: a novel cause of drug-resistant hypertension. 179
The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism 175
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 171
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 166
A useful tool to improve the case detection rate of primary aldosteronism: The aldosterone -renin ratio (ARR)-App 161
Prevalence of peri-implant diseases among an Italian population of patients with metabolic syndrome: a cross-sectional study. 157
An App for the Diagnosis of Primary Aldosteronism 148
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 147
Association between Ideal Cardiovascular Health and aortic stiffness in Italian adolescents. The MACISTE study 139
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 132
The sympathetic nervous system and catecholamines metabolism in obstructive sleep apnoea 116
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 94
Treating sleep disorders to improve blood pressure control and cardiovascular prevention: A dream come true?—a narrative review 89
Editorial: Sleep disorders, hypertension and cardiovascular diseases 57
Totale 7.562
Categoria #
all - tutte 21.815
article - articoli 21.815
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 0 26 47 28 54 39 41 25 23 26 119
2022/2023411 69 48 33 41 74 41 4 30 43 8 16 4
2023/2024212 13 26 25 18 7 40 13 4 11 23 9 23
2024/2025827 0 52 37 27 127 19 51 75 41 34 125 239
2025/20263.838 209 293 435 560 416 175 534 332 369 214 187 114
2026/2027315 153 155 7 0 0 0 0 0 0 0 0 0
Totale 7.562